Research Peptides Directory

Semaglutide is a GLP-1 weight loss drug (brand names Wegovy and Ozempic) that helps reduce appetite and control blood sugar. It's FDA-approved and is one of the most prescribed obesity medications worldwide.

Retatrutide is an investigational triple-action weight loss peptide that targets three metabolic pathways at once. In clinical trials, it's produced the strongest weight loss results ever seen from a drug — nearly 29% body weight reduction.

Tirzepatide is a dual-action weight loss drug (brand names Zepbound and Mounjaro) that targets two hormone receptors to reduce appetite and improve blood sugar. It's FDA-approved and delivers stronger weight loss than semaglutide.

Liraglutide is an FDA-approved GLP-1 weight loss and diabetes drug (brand names Saxenda and Victoza) that helps reduce appetite and control blood sugar with a daily injection.

5-Amino-1MQ is a small molecule that may boost metabolism and promote fat burning by blocking an enzyme called NNMT. It's being studied as a potential treatment for obesity and metabolic disorders.

HGH Fragment 176-191 is a fat-burning peptide derived from human growth hormone that targets body fat without the other effects of full HGH. It's essentially the fat-loss portion of growth hormone isolated on its own.

AOD-9604 is a fat-burning peptide derived from human growth hormone that may help reduce body fat without affecting blood sugar or muscle mass. It targets fat cells specifically.